403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Biovaxys Technology Corp.
(MENAFN- Baystreet) 11:14 AM EST - BioVaxys Technology Corp. : Announces that James Tartaglia, PhD, a former top R&D and commercial development executive with Sanofi Vaccines, has been appointed to the BioVaxys Board of Directors. Dr. Tartaglia fills a vacancy created by the resignation of Director Anthony Dutton, who has stepped down. BioVaxys Technology Corp.
shares C are trading -$0.03 at $0.25.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment